4-Hydroxyisoleucine ameliorates fatty acid-induced insulin resistance and inflammatory response in skeletal muscle cells

Molecular and Cellular Endocrinology

Volumn 395, Issue 1-2, 2014, Pages 51-60

  Maurya, Chandan Kumar ^a   Singh, Rohit ^a   Jaiswal, Natasha ^a   Venkateswarlu, K ^a   Narender, T ^a   Tamrakar, Akhilesh Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

4 Hydroxyisoleucine; Diabetes; Glucose uptake; Inflammation; Insulin resistance

Indexed keywords

4 HYDROXYISOLEUCINE; AKT SUBSTRATE 160; FATTY ACID; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PALMITIC ACID; PROTEIN KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4-HYDROXYISOLEUCINE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, RAT; ISOLEUCINE; LOC686547 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE; SLC2A4 PROTEIN, RAT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG STRUCTURE; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; INFLAMMATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; ISOLEUCINE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES;

EID: 84906492099     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.07.018     Document Type: Article

References (67)

1. Aguirre V., Uchida T., Yenush L., Davis R., White M.F. The c-Jun NH (2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser 307. J. Biol. Chem 2000, 275:9047-9054.
2. Batch B.C., Hyland K., Svetkey L.P. Branch chain amino acids: biomarkers of health and disease. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17:86-89.
3. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
4. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest 2002, 32:14-23.
5. Boden G.A. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
6. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest 2008, 118:789-800.
7. Borthwick A.C., Wells A.M., Rockford J.J., Hurel S.J., Turnbull D.M., Yeaman S.J. Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts. Biochem. Biophys. Res. Commun 1995, 210:738-745.
8. Bost F., Aouadi M., Caron L., Even P., Belmonte N., Prot M., et al. The extracellular signal regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 2005, 54:402-411.
9. Broca C., Rene G., Pierre P., Yves S., Manteghetti M., Tournier M., et al. 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am. J. Physiol 1999, 277:E617-E623.
10. Broca C., Manteghetti M., Gross R., Baissac Y., Jacob M., Petit P., et al. 4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretion. Eur. J. Pharmacol 2000, 390:339-435.
11. Broca C., Breil V., Cruciani-Guglielmacci C., Manteghetti M., Rouault C., Derouet M., et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am. J. Physiol. Endocrinol. Metab 2004, 287:E463-E471.
12. Carlson C.J., Koterski S., Sciotti R.J., Poccard G.B., Rondinone C.M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 2003, 52:634-641.
13. Chavez J.A., Knotts T.A., Wang L.P., Li G., Dobrowsky R.T., Florant G.L. Role of ceramide but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem 2003, 278:10297-10303.
14. Chung S., Brown J.M., Provo J.N., Hopkins R., Mclntosh M.K. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFκB-dependent cytokine production. J. Biol. Chem 2005, 280:38445-38456.
15. Cohen P. Muscle Glycogen Synthase: The Enzyme 1986, 461-496. Academic Press., NY.
16. De Fea K., Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen activated protein kinase. J. Biol. Chem 1997, 272:31400-31406.
17. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15:318-368.
18. Dimopoulos N., Watson M., Sakamoto K., Hundal H.S. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem. J. 2006, 399:473-481.
19. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest 1999, 103:253-259.
20. Eidi A., Eidi M., Sokhteh M. Effect of fenugreek (Trigonella foenum-graecum L) seeds on serum parameters in normal and streptozotocin-induced diabetic rats. Nutr. Res 2007, 27:728-733.
21. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem 1993, 268:26055-26058.
22. Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol. Endocrinol 2003, 17:487-497.
23. Gao D., Nong S., Huang X., Lu Y., Zhao H., Lin Y., et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J. Biol. Chem 2010, 285:29965-29973.
24. Guillausseau P.J., Meas T., Virally M., Laloi-Michelin M., Médeau V., Kevorkian J.P. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab 2008, 34:S43-S48.
25. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
26. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
27. Huang S., Czech M.P. The GLUT4 glucose transporter. Cell Metab 2007, 5:237-252.
28. Ikehara O., Kawasaki N., Maezono K., Komatsu M., Konishi A. Acute and chronic treatment of L-isoleucine ameliorates glucose metabolism in glucose-intolerant and diabetic mice. Biol. Pharm. Bull 2008, 31:469-472.
29. Itani S.I., Ruderman N.B., Frank S., Boden G. Lipid induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκBα. Diabetes 2002, 51:2005-2011.
30. Jaiswal N., Maurya C.K., Venkateswarlu K., Sukanya P., Srivastava A.K., Narender T., et al. 4-Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells via phosphatidylinositol-3-kinase-dependent pathway. Eur. J. Nutr 2012, 51:893-898.
31. Kahn S.E., Hull R.L., Utzscheider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
32. Kawaguchi T., Nagao Y., Matsuoka H., Ide T., Sata M. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int. J. Mol. Med 2008, 22:105-112.
33. Khan A.H., Pessin J.E. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 2002, 45:1475-1483.
34. Kishi K., Muromoto N., Nakaya Y., Miyata I., Hagi A., Hayashi H., et al. Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 1998, 47:550-558.
35. Kuwahata M., Kubota H., Kanouchi H., Ito S., Ogawa A., Kobayashi Y., et al. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease. Nutr. Res 2012, 32:522-529.
36. Lehrke M., Lazar M.A. The many faces of PPAR gamma. Cell 2005, 123:993-999.
37. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
38. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol 2003, 17:24-38.
39. McGarry J.D. Banting lecture: 2001: dysregulation of fatty acid metabolism in the aetiology of type 2 diabetes. Diabetes 2002, 51:7-18.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
41. Narender T., Puri A., Shweta, Khaliq T., Saxena R., Bhatia G., et al. 4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent. Bioorg. Med. Chem. Lett 2006, 16:293-296.
42. Nesto R.W., Bell D., Bonow R.O., Fonseca V., Grundy S.M., Horton E.S., et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003, 108:2941-2948.
43. Nishitani S., Matsumura T., Fujitani S., Sonaka I., Miura Y., Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem. Biophys. Res. Commun 2002, 299:693-696.
44. Pessin J.E., Thurmond D.C., Elmendorf J.S., Coker K.J., Okada S. Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. J. Biol. Chem 1999, 274:2593-2596.
45. Petersen K.F., Shulman G.I. New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy. Obesity 2006, 14:34S-40S.
46. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 3:813-823.
47. Prasad J., Maurya C.K., Pandey J., Jaiswal N., Madhur G., Srivastava A.K., et al. Diastereomeric mixture of calophyllic acid and isocalophyllic acid stimulates glucose uptake in skeletal muscle cells: involvement of PI-3-kinase- and ERK1/2-dependent pathways. Mol. Cell. Endocrinol 2013, 370:11-19.
48. Reynoso R., Salgado L.M., Calderon V. High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Mol. Cell. Biochem 2003, 246:155-162.
49. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest 1996, 97:2859-2865.
50. Sacks D.B., McDonald J.M. The pathogenesis of type II diabetes mellitus. A polygenic disease. Am. J. Clin. Pathol 1996, 105:149-156.
51. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
52. Sauvaire Y., Petit P., Broca C., Manteghetti M., Baissac Y., Fernandez-Alavarez J., et al. 4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes 1998, 47:206-210.
53. Sharma R.D. Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human subjects. Nutr. Res 1986, 6:1353-1364.
54. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest 2006, 116:1793-1801.
55. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest 2000, 106:171-175.
56. Sinha S., Perdomo G., Brown N.F., O'Doherty R.M. Fatty acid induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J. Biol. Chem 2004, 279:41294-41301.
57. Tamrakar A.K., Schertzer J.D., Chiu T.T., Foley K.P., Bilan P.J., Philpott D.J., et al. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. Endocrinology 2010, 151:5624-5637.
58. Tamrakar A.K., Jaiswal N., Yadav P.P., Maurya R., Srivastava A.K. Pongamol from Pongamia pinnata stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells. Mol. Cell. Endocrinol 2011, 339:98-104.
59. Tanti J.F., Jager J. Cellular mechanisms of insulin resistance: role of stress regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol 2009, 9:1-10.
60. Tilg H., Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med 2008, 14:222-231.
61. Tremblay F., Lavigne C., Jacques H., Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 2001, 50:1901-1910.
62. Ueyama A., Yaworsky K.L., Wang Q., Ebina Y., Klip A. GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity. Am. J. Physiol 1999, 277:E572-E578.
63. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., et al. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol 1999, 19:4008-4018.
64. Watson R.T., Kanzaki M., Pessin J.E. Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr. Rev 2004, 25:177-204.
65. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab 2002, 283:413-422.
66. Woodgett J.R. A common denominator linking glycogen metabolism, nuclear oncogenes and development. Trends Biochem. Sci 1991, 16:177-181.
67. Zhang Y., Guo K., LeBlanc R.E., Loh D., Schwartz G.J., Yu Y.H. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007, 56:1647-1654.